| Dr Reginald J Sanders, MD | |
|
7501 Greenway Center Dr, Suite 300, Greenbelt, MD 20770-3514 | |
| (301) 441-4577 | |
| (301) 220-0396 |
| Full Name | Dr Reginald J Sanders |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 39 Years |
| Location | 7501 Greenway Center Dr, Greenbelt, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922072198 | NPI | - | NPPES |
| 006307001 | Medicaid | VA | |
| 158751000 | Medicaid | MD | |
| 006307043 | Medicaid | VA | |
| 024859200 | Medicaid | DC |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Retina Group Of Washington, Pllc | 5294702692 | 67 |
| The Retina Group Of Washington, Pllc | 5294702692 | 67 |
News Archive
A readily available urine test could identify ulcerative colitis patients who are non-adherent to their mesalamine therapy, research shows.
The U.S. Food and Drug Administration approved Prolia, an injectable treatment for postmenopausal women with osteoporosis who are at high risk for fractures.
Pharmagesic Inc. announced today that the offer by its wholly-owned subsidiary, 7735308 Canada Limited to acquire all of the outstanding restricted voting shares of WEX Pharmaceuticals Inc. not already owned by Pharmagesic for C$0.14 cash per WEX Share has been extended to 5:00 p.m. on March 10, 2011.
In this post in The Hill's "Congress Blog," Kent Campbell, director of the Malaria Control Program at PATH, and Jonathon Simon, chair of the Department of International Health and director of the Center for Global Health and Development at the Boston University School of Public Health, write that "major progress has been made in the fight against malaria, thanks in large part to the efforts of the President's Malaria Initiative (PMI)," and call the effort "a shining example of the profound impact the U.S. is making in global health."
› Verified 3 days ago
| Entity Name | Washington National Eye Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437175684 PECOS PAC ID: 2264424043 Enrollment ID: O20040401000267 |
News Archive
A readily available urine test could identify ulcerative colitis patients who are non-adherent to their mesalamine therapy, research shows.
The U.S. Food and Drug Administration approved Prolia, an injectable treatment for postmenopausal women with osteoporosis who are at high risk for fractures.
Pharmagesic Inc. announced today that the offer by its wholly-owned subsidiary, 7735308 Canada Limited to acquire all of the outstanding restricted voting shares of WEX Pharmaceuticals Inc. not already owned by Pharmagesic for C$0.14 cash per WEX Share has been extended to 5:00 p.m. on March 10, 2011.
In this post in The Hill's "Congress Blog," Kent Campbell, director of the Malaria Control Program at PATH, and Jonathon Simon, chair of the Department of International Health and director of the Center for Global Health and Development at the Boston University School of Public Health, write that "major progress has been made in the fight against malaria, thanks in large part to the efforts of the President's Malaria Initiative (PMI)," and call the effort "a shining example of the profound impact the U.S. is making in global health."
› Verified 3 days ago
| Entity Name | The Retina Group Of Washington, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225001654 PECOS PAC ID: 5294702692 Enrollment ID: O20040915000226 |
News Archive
A readily available urine test could identify ulcerative colitis patients who are non-adherent to their mesalamine therapy, research shows.
The U.S. Food and Drug Administration approved Prolia, an injectable treatment for postmenopausal women with osteoporosis who are at high risk for fractures.
Pharmagesic Inc. announced today that the offer by its wholly-owned subsidiary, 7735308 Canada Limited to acquire all of the outstanding restricted voting shares of WEX Pharmaceuticals Inc. not already owned by Pharmagesic for C$0.14 cash per WEX Share has been extended to 5:00 p.m. on March 10, 2011.
In this post in The Hill's "Congress Blog," Kent Campbell, director of the Malaria Control Program at PATH, and Jonathon Simon, chair of the Department of International Health and director of the Center for Global Health and Development at the Boston University School of Public Health, write that "major progress has been made in the fight against malaria, thanks in large part to the efforts of the President's Malaria Initiative (PMI)," and call the effort "a shining example of the profound impact the U.S. is making in global health."
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Reginald J Sanders, MD 7501 Greenway Center Dr, Suite 300, Greenbelt, MD 20770-3514 Ph: (301) 474-4679 | Dr Reginald J Sanders, MD 7501 Greenway Center Dr, Suite 300, Greenbelt, MD 20770-3514 Ph: (301) 441-4577 |
News Archive
A readily available urine test could identify ulcerative colitis patients who are non-adherent to their mesalamine therapy, research shows.
The U.S. Food and Drug Administration approved Prolia, an injectable treatment for postmenopausal women with osteoporosis who are at high risk for fractures.
Pharmagesic Inc. announced today that the offer by its wholly-owned subsidiary, 7735308 Canada Limited to acquire all of the outstanding restricted voting shares of WEX Pharmaceuticals Inc. not already owned by Pharmagesic for C$0.14 cash per WEX Share has been extended to 5:00 p.m. on March 10, 2011.
In this post in The Hill's "Congress Blog," Kent Campbell, director of the Malaria Control Program at PATH, and Jonathon Simon, chair of the Department of International Health and director of the Center for Global Health and Development at the Boston University School of Public Health, write that "major progress has been made in the fight against malaria, thanks in large part to the efforts of the President's Malaria Initiative (PMI)," and call the effort "a shining example of the profound impact the U.S. is making in global health."
› Verified 3 days ago
Joseph Mekhail, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7500 Greenway Center Dr Ste 300, Greenbelt, MD 20770 Phone: 301-277-4844 | |
Jason Mingyi Huang, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7501 Greenway Center Dr # 300, Greenbelt, MD 20770 Phone: 301-474-4679 | |
Dr. Geoffrey R Kaplan, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7501 Greenway Center Dr, Suite # 300, Greenbelt, MD 20770 Phone: 301-441-4577 Fax: 301-220-0396 | |
Mariam Mathai, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7501 Greenway Center Dr # 300, Greenbelt, MD 20770 Phone: 301-474-4679 Fax: 301-474-7182 | |
Sneha Padidam, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7501 Greenway Center Dr Ste 300, Greenbelt, MD 20770 Phone: 301-474-4679 Fax: 301-474-7182 | |
Mr. Stephen Melvyn Solomon, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7500 Hanover Pkwy, Ste 101b, Greenbelt, MD 20770 Phone: 301-982-4565 Fax: 301-982-4252 | |
Mr. Jonathan David Solomon, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7500 Hanover Pkwy, Ste 101b, Greenbelt, MD 20770 Phone: 301-982-4565 Fax: 301-982-4252 |